Meet the Member: Oxford University Hospitals
Dr Rubeta Matin is an academic dermatologist with internationally recognised expertise in diagnosis and management of skin cancers and skin disease in the immunosuppressed. She currently holds the post of Consultant Dermatologist at Oxford University Hospitals NHS Foundation Trust where she leads the Oxford specialist Transplant/Immunosuppressed clinic and provides dedicated skin expertise to leading Haematologists and Oncologists at Oxford. She had a pivotal role in the set up of Extracorporeal photopheresis services in Oxfordshire.
She has an international reputation as a skin cancer leader and has published more than 100 high impact, peer-reviewed journal publications as well as being frequently invited to present nationally and internationally. She achieved a PhD in Molecular Mechanisms in Melanoma at the University of London in 2010. At Oxford, she is currently Dermatology Research Lead for Skin Cancer actively undertaking clinical research trials in skin cancer management.
Dr Matin holds a number of national roles within multi-disciplinary groups to enable successful collaborative research. She is currently Executive Board Member of the UK Dermatology Clinical Trials Network, member of the MHRA Software Expert Advisory Group and MHRA Interim Medical Devices Group. Since September 2020 she has Chaired the Artificial Intelligence Working Party Group (at the British Association of Dermatologists) providing national leadership on directing the development and adoption of AI for UK Dermatology.
The UK Photopheresis Society 